NVONOVO NORDISK A S

NYSE novonordisk.com


$ 139.10 $ -4.11 (-2.87 %)    

Wednesday, 03-Jul-2024 12:59:59 EDT
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 138.87
$ 141.09
$ 0.00 x 0
$ 0.00 x 0
$ 136.05 - $ 141.46
$ 74.66 - $ 148.15
7,455,753
na
626,304
$ 0.64
$ 0.00
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sp-500-nasdaq-100-climb-to-record-highs-as-data-fosters-rate-cut-optimism-ahead-of-fed-minutes-gold-bonds-rally-whats-driving-markets-wednesday

The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for...

 using-obesity-drugs-potential-vision-loss-disorder-linked-to-novo-nordisks-ozempic-and-wegovy-study-finds

New study suggests a potential link between Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, and NAION, a condition that can...

Core News & Articles

https://www.statnews.com/2024/07/03/ozempic-wegovy-naion-vision-loss-study/A new observational study on Wednesday reported for ...

Core News & Articles

https://nypost.com/2024/07/03/lifestyle/potential-link-between-ozempic-wegovy-and-serious-eye-condition-study/Researchers say t...

 joe-biden-suggests-novo-nordisk-eli-lilly-to-lower-prices-for-its-popular-obesity-drugs

American leaders push for lower drug prices, highlighting recent legislation and widespread support for affordable medications....

Core News & Articles

- Reuters

Core News & Articles

https://www.usatoday.com/story/opinion/2024/07/02/biden-sanders-prescription-drug-cost-ozempic-wegovy/74232827007/

 cantor-fitzgerald-reiterates-overweight-on-novo-nordisk-maintains-160-price-target

Cantor Fitzgerald analyst Louise Chen reiterates Novo Nordisk (NYSE:NVO) with a Overweight and maintains $160 price target.

 novo-nordisk-buys-2seventys-hemophilia-a-program-divestiture-supports-exclusive-focus-on-abecma

2seventy Bio finalized an asset purchase agreement with Novo Nordisk involving the Hemophilia A program and in vivo gene editin...

 volkswagen-puts-our-rivian-bet-in-the-black-the-pros-and-cons-of-trading-options-versus-stocks

Novo Nordisk, Carvana, And Now Rivian  We've had bullish moves in three stocks we had bullish bets on this week, and since...

 novo-nordisk-to-restrict-initial-wegovy-sales-in-china-amid-high-demand

Novo Nordisk will limit initial sales of Wegovy in China to manage global supply and address the rising obesity rates in the wo...

 hims--hers-health-stock-is-sliding-thursday-whats-going-on

Hunterbrook releases a bearish report alleging that Hims & Hers sells knockoff GLP-1 weight loss drugs and relies on a sing...

Core News & Articles

https://www.bloomberg.com/news/articles/2024-06-27/novo-will-limit-wegovy-s-china-launch-to-avoid-global-disruption?utm_content...

 ben--jerrys-co-founders-not-worried-about-ozempics-impact-on-ice-cream-business-heres-why

Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry's, are not worried about the impact of weight-loss drugs...

Core News & Articles

- Divestiture Supports Company Focus on Development and Commercialization of Abecma-